Evolutionary dynamics of the multidrug-resistant Salmonella Infantis harbouring the pESI megaplasmid across Europe

Patricia Alba1, Elena Lavinia Diaconu1, Virginia Carfora1

  • 1Department of General Diagnostics, National Reference Laboratory for Antimicrobial Resistance, Istituto Zooprofilattico Sperimentale del Lazio e della Toscana "M. Aleandri", Rome, Italy.

Microbial Genomics
|July 13, 2026
PubMed

Insights

A multidrug-resistant Salmonella Infantis clone carrying the pESI megaplasmid circulates globally. This study reveals two main pESI variants in Europe, differing in accessory genes and conferring antimicrobial resistance, impacting One Health surveillance.

Area of Science:

  • Microbiology
  • Genomics
  • Epidemiology

Background:

  • Multidrug-resistant *Salmonella enterica* subsp. *enterica* serovar Infantis* (S. Infantis) clone, associated with the pESI megaplasmid, emerged in Israel in 2014 and is now a global concern in poultry and humans.
  • This clone exhibits resistance to multiple antibiotics, including sulphonamides, tetracycline, streptomycin, and spectinomycin, with increasing detection of extended-spectrum beta-lactamase (ESBL) genes like *bla*CTX-M-1.

Purpose of the Study:

  • To investigate the genomic epidemiology of *S. Infantis* in Europe, analyzing samples from human, food, and animal sources.
  • To understand the evolutionary dynamics of pESI-like plasmids within Europe and compare them globally in a One Health context.

Main Methods:

  • Utilized a combination of short- and long-read sequencing approaches for comprehensive genomic analysis.
  • Collected and analyzed *S. Infantis* samples from nine European Public Health Institutions between 2011 and 2021.
  • Compared European pESI-like sequences with publicly available global sequences.

Main Results:

  • Identified the circulation of a *S. Infantis* clone in Europe carrying a mosaic pESI-like megaplasmid, associated with specific antimicrobial resistance genes (*sul*, *tet*, *aadA1*).
  • Detected two main types of pESI variants in Europe, differing in accessory gene content, including *bla*CTX-M variants, indicating stability across different regions and sources over a decade (2011-2021).
  • Observed that variations in pESI variants are linked to the acquisition of resistance, virulence, or fitness-enhancing genes.

Conclusions:

  • The study confirms the sustained circulation of a specific multidrug-resistant *S. Infantis* clone and its pESI-like megaplasmid variants in Europe.
  • The genomic diversity of pESI variants suggests ongoing evolution and adaptation, potentially conferring advantages to the *Salmonella* host.
  • Findings underscore the importance of integrated genomic surveillance across human, animal, and food sources for effective One Health antimicrobial resistance monitoring.

Related Concept Videos

Evolution of Microbial Genome01:08

Evolution of Microbial Genome

Microbial genome evolution is a highly dynamic process shaped by continual gene gain and loss across species and strains. This genomic flexibility allows microorganisms to adapt rapidly to environmental pressures and interactions with other organisms. Central to understanding this diversity is the distinction between the core and pan genomes.The core genome comprises the genes shared by all sampled strains of a species, representing essential functions needed for fundamental cellular processes.
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Plasmids01:28

Plasmids

Plasmids are extrachromosomal DNA molecules found in bacteria, archaea, and some eukaryotic microbes like yeast. These small, circular DNA structures typically contain fewer than 30 genes, although some may exist linearly. Plasmids vary in their number within a cell, known as copy number. Single-copy plasmids are present in one copy per cell and multi-copy plasmids are present in multiple copies, reaching over 100 copies per cell.Plasmids usually replicate independently of the chromosomal DNA...
Evolution of New Traits in Microbes01:24

Evolution of New Traits in Microbes

Microorganisms evolve rapidly due to their large population sizes and short generation times, often exhibiting measurable changes within days under laboratory conditions. Natural selection acts on standing genetic variation, enabling the retention and amplification of beneficial traits that confer fitness advantages in changing environments.Adaptive Pigment Regulation in RhodobacterIn Rhodobacter, a genus of purple non-sulfur bacteria, light-harvesting pigments such as bacteriochlorophyll and...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...